Federal contract award
HT942523C0069
DHA SEQUENTIAL PHASE II SBIR DEPLOYABLE WOUND CARE PRODUCTS TO DECREASE PREVENTABLE DEATH OUTCOMES BY MITIGATING INFECTION ON BATTLEFIELD AND THROUGH LONG TERM CARE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.3M |
| Current contract value | $1.3M |
| Potential contract value / ceiling | $1.3M |
| Start date | Sep 22, 2023 |
| Current end date | Apr 21, 2027 |
| Potential end date | Apr 21, 2027 |
| Latest award activity | Jun 2, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 2, 2026 | P00004 | $0 | DEPLOYABLE WOUND CARE PRODUCTS TO DECREASE PREVENTABLE DEATH OUTCOMES BY MITIGATING INFECTION ON BATTLEFIELD AND THROUGH LONG TERM CARE |
| May 26, 2026 | P00003 | $0 | DEPLOYABLE WOUND CARE PRODUCTS TO DECREASE PREVENTABLE DEATH OUTCOMES BY MITIGATING INFECTION ON BATTLEFIELD AND THROUGH LONG TERM CARE |
| Jul 16, 2025 | P00002 | $0 | DHA SEQUENTIAL PHASE II SBIR DEPLOYABLE WOUND CARE PRODUCTS TO DECREASE PREVENTABLE DEATH OUTCOMES BY MITIGATING INFECTION ON BATTLEFIELD ANDTHROUGH LONG TERM CARE |
| Jul 2, 2025 | P00001 | $0 | DHA SEQUENTIAL PHASE II SBIR DEPLOYABLE WOUND CARE PRODUCTS TO DECREASE PREVENTABLE DEATH OUTCOMES BY MITIGATING INFECTION ON BATTLEFIELD AND THROUGH LONG TERM CARE |
| Sep 20, 2023 | 0 | $1.3M | DHA SEQUENTIAL PHASE II SBIR DEPLOYABLE WOUND CARE PRODUCTS TO DECREASE PREVENTABLE DEATH OUTCOMES BY MITIGATING INFECTION ON BATTLEFIELD AND THROUGH LONG TERM CARE |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-04-21 (178 days from calculation)
- +35 points
- 12 historical awards in this buyer and category group
- +15 points
- 5 recorded award transactions
- +10 points
- Latest award action: 2026-06-02
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.